EBR:ACKB

Ackermans & Van Haaren Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume21,215 shs
Average Volume32,496 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Ackermans & Van Haaren (EBR:ACKB) Vs. DWS, GLJ, MLP, DBAN, BME, and BKT

Should you be buying ACKB stock or one of its competitors? Companies in the industry of "asset management" are considered alternatives and competitors to Ackermans & Van Haaren, including DWS Group GmbH & Co. KGaA (DWS), Grenke (GLJ), MLP (MLP), Deutsche Beteiligungs (DBAN), BlackRock Health Sciences Trust (BME), and BlackRock Income Trust (BKT).

Ackermans & Van Haaren (EBR:ACKB) and DWS Group GmbH & Co. KGaA (ETR:DWS) are both financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Profitability

This table compares Ackermans & Van Haaren and DWS Group GmbH & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ackermans & Van HaarenN/AN/AN/A
DWS Group GmbH & Co. KGaAN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and price targets for Ackermans & Van Haaren and DWS Group GmbH & Co. KGaA, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ackermans & Van Haaren0000N/A
DWS Group GmbH & Co. KGaA021102.85

DWS Group GmbH & Co. KGaA has a consensus price target of €38.66, suggesting a potential upside of 0.62%.

Earnings & Valuation

This table compares Ackermans & Van Haaren and DWS Group GmbH & Co. KGaA's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ackermans & Van HaarenN/AN/AN/AN/AN/A
DWS Group GmbH & Co. KGaA$3.35 billion2.30$556 million€2.7813.82

DWS Group GmbH & Co. KGaA has higher revenue and earnings than Ackermans & Van Haaren.

Summary

DWS Group GmbH & Co. KGaA beats Ackermans & Van Haaren on 2 of the 2 factors compared between the two stocks.

Ackermans & Van Haaren (EBR:ACKB) and Grenke (ETR:GLJ) are both financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares Ackermans & Van Haaren and Grenke's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ackermans & Van HaarenN/AN/AN/AN/AN/A
Grenke$537.48 million2.83$86.81 million€1.8717.52

Grenke has higher revenue and earnings than Ackermans & Van Haaren.

Analyst Recommendations

This is a summary of current ratings and price targets for Ackermans & Van Haaren and Grenke, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ackermans & Van Haaren0000N/A
Grenke12402.43

Grenke has a consensus price target of €67.14, suggesting a potential upside of 105.27%.

Profitability

This table compares Ackermans & Van Haaren and Grenke's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ackermans & Van HaarenN/AN/AN/A
GrenkeN/AN/AN/A

Summary

Grenke beats Ackermans & Van Haaren on 2 of the 2 factors compared between the two stocks.

MLP (ETR:MLP) and Ackermans & Van Haaren (EBR:ACKB) are both financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares MLP and Ackermans & Van Haaren's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MLP$767.30 million0.99$43.50 million€0.4017.50
Ackermans & Van HaarenN/AN/AN/AN/AN/A

MLP has higher revenue and earnings than Ackermans & Van Haaren.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for MLP and Ackermans & Van Haaren, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MLP01102.50
Ackermans & Van Haaren0000N/A

MLP presently has a consensus price target of €7.45, suggesting a potential upside of 6.43%.

Profitability

This table compares MLP and Ackermans & Van Haaren's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MLPN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/A

Summary

MLP beats Ackermans & Van Haaren on 2 of the 2 factors compared between the two stocks.

Deutsche Beteiligungs (ETR:DBAN) and Ackermans & Van Haaren (EBR:ACKB) are both financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares Deutsche Beteiligungs and Ackermans & Van Haaren's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deutsche Beteiligungs$39.80 million13.57$8.88 million€0.5960.85
Ackermans & Van HaarenN/AN/AN/AN/AN/A

Deutsche Beteiligungs has higher revenue and earnings than Ackermans & Van Haaren.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Deutsche Beteiligungs and Ackermans & Van Haaren, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Deutsche Beteiligungs00503.00
Ackermans & Van Haaren0000N/A

Deutsche Beteiligungs presently has a consensus price target of €45.44, suggesting a potential upside of 26.57%.

Profitability

This table compares Deutsche Beteiligungs and Ackermans & Van Haaren's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Deutsche BeteiligungsN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/A

Summary

Deutsche Beteiligungs beats Ackermans & Van Haaren on 2 of the 2 factors compared between the two stocks.

BlackRock Health Sciences Trust (BME:BME) and Ackermans & Van Haaren (EBR:ACKB) are both financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares BlackRock Health Sciences Trust and Ackermans & Van Haaren's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for BlackRock Health Sciences Trust and Ackermans & Van Haaren, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Health Sciences Trust0000N/A
Ackermans & Van Haaren0000N/A

Profitability

This table compares BlackRock Health Sciences Trust and Ackermans & Van Haaren's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Health Sciences TrustN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/A

BlackRock Income Trust (BME:BKT) and Ackermans & Van Haaren (EBR:ACKB) are both financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Earnings and Valuation

This table compares BlackRock Income Trust and Ackermans & Van Haaren's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Income TrustN/AN/AN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations for BlackRock Income Trust and Ackermans & Van Haaren, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Income Trust0000N/A
Ackermans & Van Haaren0000N/A

Profitability

This table compares BlackRock Income Trust and Ackermans & Van Haaren's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Income TrustN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/A


Ackermans & Van Haaren Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DWS Group GmbH & Co. KGaA logo
DWS
DWS Group GmbH & Co. KGaA
1.9$38.42flat$7.68 billion$3.35 billion13.82Analyst Report
High Trading Volume
News Coverage
Grenke logo
GLJ
Grenke
1.8$32.71flat$1.52 billion$537.48 million17.52High Trading Volume
MLP logo
MLP
MLP
1.3$7.00flat$761.32 million$767.30 million17.50
Deutsche Beteiligungs logo
DBAN
Deutsche Beteiligungs
1.7$35.90flat$540.08 million$39.80 million60.85
BlackRock Health Sciences Trust logo
BME
BlackRock Health Sciences Trust
0.5N/AN/A$0.00N/A0.00
BlackRock Income Trust logo
BKT
BlackRock Income Trust
0.4N/AN/A$0.00N/A0.00
BNY Mellon Strategic Municipal Bond Fund logo
DSM
BNY Mellon Strategic Municipal Bond Fund
0.6N/AN/A$0.00N/A0.00
Groupe Bruxelles Lambert logo
GBLB
Groupe Bruxelles Lambert
0.7N/AN/A$0.00N/A0.00
Rand Capital logo
RAND
Rand Capital
0.4N/AN/A$0.00N/A0.00News Coverage
PYX
Schroders
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.